Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

  • There is currently no data for MIX

1st Quarter Results

14 May 2020 14:30

RNS Number : 9563M
Mobeus Income & Growth VCT PLC
14 May 2020
 

 

Mobeus Income & Growth VCT plc ("the Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 March 2020

 

Mobeus Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 31 March 2020. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE & CUMULATIVE TOTAL RETURN PER SHARE

At 31 March 2020

(unaudited)

At 31 December 2019

(audited)

Net assets attributable to shareholders

£72.89 million

£71.89 million

Shares in issue

124,007,350

104,526,507

Net asset value (NAV) per share

58.78 pence

68.78 pence

Cumulative dividends paid

128.80 pence

124.80 pence

Cumulative Total return (net asset value basis) per share since inception

187.58 pence

193.58 pence

 

The fall in the NAV per share of 10.00 pence over the quarter was due principally to two factors. Firstly a further interim dividend for the 2019 financial year of 4.00 pence per share was paid on 8 January 2020 (detailed under Dividends below); secondly, despite the positive impact upon the NAV per share from the sale of Turner TopCo Limited on 13 February 2020 (detailed under Realisations below), the Company's portfolio valuations at 31 March 2020 have been reduced in response to the economic disruption and market conditions resulting from the outbreak of the COVID-19 global pandemic. This resulted in a net fall from portfolio movements for the quarter of 6.00 pence in NAV per share.

 

On 26 March 2020, due to the COVID-19 global pandemic, the Company had issued an unaudited NAV of 58.95 pence per share as at 24 March 2020, which figure formed the basis of the offer price at which shares were allotted to investors on 2 April 2020.

 

DIVIDENDS

On 8 January 2020, an Interim dividend of 4.00 pence per ordinary share in respect of the year ended 31 December 2019 was paid to all Shareholders whose names were on the Register on 27 December 2019.

 

After the period end, on 7 May 2020, an Interim dividend of 6.00 pence per ordinary share in respect of the year ending 31 December 2020 was paid to all Shareholders whose names were on the Register on 14 April 2020. Payment of this dividend has reduced the NAV per share at 31 March 2020 of 58.78 pence to 52.78 pence and increased cumulative dividends paid to 134.80 pence per share.

 

FUNDRAISING

On 8 January 2020, the Company carried out its first allotment in respect of its offer for subscription launched on 25 October 2019, allotting 19,480,843 ordinary shares, at an average effective offer price of 65.20 pence per share. This allotment generated net funds of £12.27 million due to the Company.

 

Shortly after the period end, on 2 April 2020, the Company carried out its second and final allotment of shares under this offer, allotting 3,752,450 ordinary shares at an average price of 61.25 pence per share. This allotment generated net funds of £2.21 million due to the Company.

 

Following the second of these two allotments, the Company's offer was formally closed having been fully subscribed (including its over-allotment facility), raising net funds totalling £14.48 million.

 

 

REALISATIONS

On 7 February 2020, the Company realised its investment in Pattern Analytics Limited (trading as Biosite), a provider of workforce management and security services, generating proceeds of £2.34 million in the period. The Company received £2.45 million in cash over the life of the investment and generated a return on original cost of 1.5x and an IRR of 21.0% in the three years that the investment was held.

 

On 13 February 2020, the Company realised its investment in Turner Topco Limited (trading as Auction Technology Group), an online auction marketplace platform, generating proceeds of £8.62 million in the period, including £1.78 million of loan interest which was due upon completion. Over the life of the investment total proceeds of £14.77 million have been received, an overall multiple over cost of 4.5x and an IRR of 28.9%.

 

 

NEW & FURTHER INVESTMENTS

The Company made no new investments during the quarter.

On 5 May 2020, the Company invested a further £0.57 million into an existing portfolio company, Rota Geek Limited, a workforce management software provider.

 

SHARE BUYBACKS

On 9 April 2020, the Company repurchased 755,416 of its own ordinary shares at a price of 50.30 pence per share for cancellation.

 

Following this share buyback and cancellation there are now 127,004,384 ordinary shares of 1 penny each in issue.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRFFLFFVELISLII
Date   Source Headline
18th Jun 202511:15 amRNSChange of Name
9th Jun 202512:30 pmRNSRealisation of investment in Rota Geek Limited
2nd Jun 20257:00 amRNSRealisation of investment in My Tutorweb Limited
1st May 20257:00 amRNSTotal Voting Rights
11th Apr 20252:00 pmRNSIssue of Equity and Total Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20257:00 amRNSTransaction in own shares and Total Voting Rights
5th Mar 20256:01 pmRNSResult of AGM
5th Mar 20253:55 pmRNSInterim Management Statement
5th Mar 202512:25 pmRNSDividend Declaration
3rd Mar 20252:30 pmRNSTotal Voting Rights and Capital
26th Feb 20254:00 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSTotal Voting Rights
21st Jan 20252:00 pmRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20254:06 pmRNSAnnual Financial Report
2nd Dec 20247:00 amRNSTotal Voting Rights and Capital
28th Oct 20242:05 pmRNSDirector/PDMR Shareholding
28th Oct 20242:00 pmRNSIssue of Equity and Total Voting Rights
15th Oct 202411:15 amRNSOFFER FOR SUBSCRIPTION - UPDATE
2nd Oct 20247:00 amRNSIssue of Equity
26th Sep 20249:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Sep 20241:06 pmRNSHalf-year Report
18th Sep 202410:00 amRNSOffer for Subscription – Update
2nd Sep 20243:15 pmRNSOffer for Subscription – Open for Applications
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights and Capital
26th Jul 20243:00 pmRNSDirector/PDMR Shareholding
26th Jul 20242:00 pmRNSGENERAL MEETINGS AND MERGER RESULTS
24th Jul 20244:15 pmRNSNet Asset Value(s)
18th Jul 20241:32 pmRNSMERGER UPDATE AND GENERAL MEETINGS
4th Jul 20247:00 amRNSTransaction in Own shares and Total Voting Rights
1st Jul 20249:42 amRNSTotal Voting Rights and Capital
18th Jun 20245:30 pmRNSPROPOSED MERGER AND OFFERS
10th Jun 20244:00 pmRNSMerger Proposals/Intention To Launch Joint Offers
3rd Jun 20247:00 amRNSTotal Voting Rights and Capital
28th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th May 20245:34 pmRNSResult of Annual General Meeting
20th May 20247:00 amRNSInterim Management Statement
1st May 20247:00 amRNSTotal Voting Rights and Capital
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSDividend Declaration
15th Apr 20247:00 amRNSAnnual Financial Report
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
22nd Feb 202411:00 amRNSNet Asset Value(s)
1st Feb 202411:46 amRNSVoting Rights and Capital
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202312:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.